TI
CO

Trexquant Investment’s Global Cord Blood Corporation CO Stock Holding History

Trexquant Investment’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25,274
Closed -$251K – 1569
2017
Q4 		$251K Buy
25,274
+4,035
+19% +$44.1K 0.03% 825
2017
Q3 		$236K Buy
+21,239
New +$249K 0.06% 558

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SAM
Silphium Asset Management London, United Kingdom $264M AUM 19.59% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Trexquant Investment's CO Position: Q1 2018 in Review

Trexquant Investment sold out of Global Cord Blood Corporation (CO) in Q1 2018, closing a stake of 25,274 shares — an estimated $251K sold.

Trexquant Investment first reported a position in CO in Q3 2017 and held it in 2 quarters. The position peaked at $251K in Q4 2017. 58 funds tracked by Wall St. Rank hold CO as of Q1 2018.

  • Trexquant Investment reported no remaining Global Cord Blood Corporation position as of Q1 2018 after selling out during the quarter.
  • Trexquant Investment sold 25,274 Global Cord Blood Corporation shares in Q1 2018, an estimated $251K.
  • Trexquant Investment first reported a position in Global Cord Blood Corporation in Q3 2017 and held it in 2 quarters.
  • Trexquant Investment's Global Cord Blood Corporation position peaked at $251K in Q4 2017.
  • 58 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2018.

Based on Trexquant Investment's 13F filing for Q1 2018, filed 3 May 2018.